Gauss

Fbln5 25 µg

Réf. UGAP : 3788739 Réf. Fournisseur : 16142686 Réf. Constructeur : H00010516-P01
Fbln5 25 µg
Franco de port et d'emballage pour toutes les commandes supérieures à 80€ HT.
Produit ni repris ni échangé excepté en cas d’erreur du prestataire.
La quantité choisie doit être comprise entre 1 et 999 999.

Points clés

Used for AP, Array, ELISA, WB-Re

The protein encoded by this gene is a secreted, extracellular matrix protein containing an Arg-Gly-Asp (RGD) motif and calcium-binding EGF-like domains. It promotes adhesion of endothelial cells through interaction of integrins and the RGD motif. It is prominently expressed in developing arteries but less so in adult vessels. However, its expression is reinduced in balloon-injured vessels and atherosclerotic lesions, notably in intimal vascular smooth muscle cells and endothelial cells. Therefore, the protein encoded by this gene may play a role in vascular development and remodeling. Defects in this gene are a cause of autosomal dominant cutis laxa, autosomal recessive cutis laxa type I (CL type I), and age-related macular degeneration type 3 (ARMD3). [provided by RefSeq]

En savoir plus

Garantie

Garantie 0 Mois

Description

Used for AP, Array, ELISA, WB-Re

The protein encoded by this gene is a secreted, extracellular matrix protein containing an Arg-Gly-Asp (RGD) motif and calcium-binding EGF-like domains. It promotes adhesion of endothelial cells through interaction of integrins and the RGD motif. It is prominently expressed in developing arteries but less so in adult vessels. However, its expression is reinduced in balloon-injured vessels and atherosclerotic lesions, notably in intimal vascular smooth muscle cells and endothelial cells. Therefore, the protein encoded by this gene may play a role in vascular development and remodeling. Defects in this gene are a cause of autosomal dominant cutis laxa, autosomal recessive cutis laxa type I (CL type I), and age-related macular degeneration type 3 (ARMD3). [provided by RefSeq]

Caractéristiques

Type d'antibiotique
non
Type d'enzyme
non
Domaine de recherche
protéomique
Type de protéine
oui
Marque
ABNOVA
Référence distributeur
16142686
Fournisseur
FISHER SCIENTIFIC S.A.S.
Dispositif stérile
non
Marquage CE DIV
non
Code à barre
non
Type d'acide nucléique extrait
non
Origine humaine
non
Sans composant animal
non
Vendu par
25 ug
Délai de péremption à la date de livraison
12 mois
Température de conservation (°C)
-80 °C
Température de transport
carboglace
Soumis à carboglace
oui
Classification REACH
non
Nomenclature IFPEN
NA.56
Nomenclature DGOS
LD10AOOO
Code douanier
38221900
Reprise en cas d’erreur client
non
Type de produit
protéine
Nomenclature Nacres
NA.56
Nomenclature IRSN
273
Nomenclature INSERM
NA.NA56
Type d’application
ELISA, western blot
Lieu de stockage
France
Nomenclature CHU
18.551
Autres caractéristiques
Abnova Human FBLN5 Full-length ORF (BAG52073.1, 1 a.a. - 448 a.a.) Recombinant Protein with GST-tag at N-terminal, Quantity: 25 ug, Format: Liquid, Formulation: 50mM Tris-HCI, 10mM reduced Glutathione, pH-8.0 in the elution buffer., Host Species: Whe
Lieu de fabrication
Taïwan
Nomenclature CEA
SGP01
Nomenclature CNRS
NA56
Type d'échantillon
protéine
Matière dangereuse
oui
Quantité
N/A
Libellé produit fabricant
25ug fbln5 (human) recombinant protein (p01)
Référence fabricant
H00010516-P01
Certification
RUO